Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Medicure (MCUJF) Receivables (2016 - 2025)

Medicure has reported Receivables over the past 17 years, most recently at $3.5 million for Q4 2025.

  • For Q4 2025, Receivables fell 7.74% year-over-year to $3.5 million; the TTM value through Dec 2025 reached $3.5 million, down 7.74%, while the annual FY2025 figure was $3.5 million, 7.74% down from the prior year.
  • Receivables for Q4 2025 was $3.5 million at Medicure, up from $595114.1 in the prior quarter.
  • Over five years, Receivables peaked at $4.7 million in Q2 2022 and troughed at -$1.1 million in Q1 2022.
  • A 5-year average of $657747.6 and a median of $199694.0 in 2024 define the central range for Receivables.
  • On a YoY basis, Receivables climbed as much as 6348.99% in 2022 and fell as far as 340.65% in 2022.
  • Year by year, Receivables stood at $522808.5 in 2021, then plummeted by 206.25% to -$555474.0 in 2022, then skyrocketed by 249.16% to $828556.1 in 2023, then surged by 360.76% to $3.8 million in 2024, then decreased by 7.74% to $3.5 million in 2025.
  • Business Quant data shows Receivables for MCUJF at $3.5 million in Q4 2025, $595114.1 in Q3 2025, and $153724.8 in Q2 2025.